ATE85523T1 - Taurohyodeoxycholsaeure zur behandlung von gallenwegssteinen und gallenstoerungen. - Google Patents

Taurohyodeoxycholsaeure zur behandlung von gallenwegssteinen und gallenstoerungen.

Info

Publication number
ATE85523T1
ATE85523T1 AT88108373T AT88108373T ATE85523T1 AT E85523 T1 ATE85523 T1 AT E85523T1 AT 88108373 T AT88108373 T AT 88108373T AT 88108373 T AT88108373 T AT 88108373T AT E85523 T1 ATE85523 T1 AT E85523T1
Authority
AT
Austria
Prior art keywords
biliary
treatment
stones
disorders
taurohyodeoxycholic acid
Prior art date
Application number
AT88108373T
Other languages
English (en)
Inventor
Mario Angelico
Simos Contos
Original Assignee
Enosys Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enosys Sa filed Critical Enosys Sa
Application granted granted Critical
Publication of ATE85523T1 publication Critical patent/ATE85523T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT88108373T 1987-06-03 1988-05-26 Taurohyodeoxycholsaeure zur behandlung von gallenwegssteinen und gallenstoerungen. ATE85523T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT8720771A IT1212141B (it) 1987-06-03 1987-06-03 Composizioni farmaceutiche per la prevenzione e terapia della calcolosi delle vie biliari e della dispepsia biliare.
EP88108373A EP0293751B1 (de) 1987-06-03 1988-05-26 Taurohyodeoxycholsäure zur Behandlung von Gallenwegssteinen und Gallenstörungen

Publications (1)

Publication Number Publication Date
ATE85523T1 true ATE85523T1 (de) 1993-02-15

Family

ID=11171828

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88108373T ATE85523T1 (de) 1987-06-03 1988-05-26 Taurohyodeoxycholsaeure zur behandlung von gallenwegssteinen und gallenstoerungen.

Country Status (7)

Country Link
US (1) US4917898A (de)
EP (1) EP0293751B1 (de)
JP (1) JP2649699B2 (de)
AT (1) ATE85523T1 (de)
DE (1) DE3878313T2 (de)
ES (1) ES2045009T3 (de)
IT (1) IT1212141B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1245889B (it) * 1991-04-12 1994-10-25 Alfa Wassermann Spa Formulazioni farmaceutiche per uso orale gastroresistenti contenenti sali di acidi biliari.
IT1245890B (it) * 1991-04-12 1994-10-25 Alfa Wassermann Spa Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari.
IT1245891B (it) 1991-04-12 1994-10-25 Alfa Wassermann Spa Formulazioni farmaceutiche a rilascio controllato per uso orale gastroresistenti contenenti acidi biliari e loro sali.
CH680704A5 (de) * 1991-05-15 1992-10-30 Medichemie Ag
IT1249686B (it) * 1991-07-22 1995-03-09 Boniscontro E Gazzone S R L Preparazioni farmaceutiche orali, a base di acidi biliari, a cessione protratta e controllata con le quali e' possibile adottare una sola somministrazione giornaliera
IT1257793B (it) * 1992-05-18 1996-02-13 Composizione farmaceutica a base di acidi biliari in microgranuli a rilascio controllato
GR920100437A (el) * 1992-10-12 1994-06-30 Boniscontro E Gazzone S R L Φαρμακευτικά σκευάσματα βραδείας απελευ?έρωσης χορηγούμενα από του στόματος και περιέχοντα χολικά οξέα.
ES2059262B1 (es) * 1992-10-13 1995-10-01 Boniscontro E Gazzone S R L Composiciones farmaceuticas orales de liberacion sostenida conteniendo acidos biliares.
DE29717252U1 (de) * 1997-09-26 1998-02-19 Dr. Falk Pharma GmbH, 79108 Freiburg Arzneimittelkit aus einem Budesonid-haltigen und einem Ursodesoxycholsäure-haltigen Arzneimittel zur Behandlung von cholestatischen Lebererkrankungen
US7012069B2 (en) * 2001-05-03 2006-03-14 Arch Development Corporation Liver X receptor agonists
EP1189922A4 (de) * 1999-04-30 2002-08-14 Arch Dev Corp Steroid derivate
US7078396B2 (en) * 2001-05-03 2006-07-18 Arch Development Corporation Method of treating disorder related to high cholesterol concentration
US20070197484A1 (en) * 2001-05-03 2007-08-23 Ching Song Method of treating disorder related to high cholesterol concentration
AU2003228485A1 (en) * 2002-04-12 2003-10-27 The University Of Chicago Farnesoid x-activated receptor agonists
KR20030097067A (ko) * 2002-06-19 2003-12-31 현대자동차주식회사 자동차의 델터 커버
US20060074057A1 (en) * 2004-10-04 2006-04-06 Eric Marchewitz Use of chenodeoxycholic acid for reducing adipose tissue
US20070032464A1 (en) * 2004-10-08 2007-02-08 Shutsung Liao Methods of treating cancers
US20060276812A1 (en) * 2005-04-04 2006-12-07 Hill James W Dynamic reinforcement of the lower esophageal sphincter
US8829213B2 (en) * 2009-07-29 2014-09-09 The University Of Chicago Liver X receptor agonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1101649B (it) * 1978-12-15 1985-10-07 Lehner Ag Composizione farmaceutica ad azione prolungata contenente acidi biliari
IT1196377B (it) * 1984-12-21 1988-11-16 Lehner Ag Derivati di acidi biliari,procedimento per la loro preparazione e relative composizioni farmaceutiche
JPS61158995A (ja) * 1984-12-28 1986-07-18 Takara Shironaga 脂肪肝，胆石，胃粘膜障害発生の予防薬または治療薬

Also Published As

Publication number Publication date
IT8720771A0 (it) 1987-06-03
IT1212141B (it) 1989-11-08
JPS6463522A (en) 1989-03-09
EP0293751A2 (de) 1988-12-07
JP2649699B2 (ja) 1997-09-03
EP0293751B1 (de) 1993-02-10
DE3878313T2 (de) 1993-05-27
ES2045009T3 (es) 1994-01-16
EP0293751A3 (en) 1990-07-25
US4917898A (en) 1990-04-17
DE3878313D1 (de) 1993-03-25

Similar Documents

Publication Publication Date Title
ATE85523T1 (de) Taurohyodeoxycholsaeure zur behandlung von gallenwegssteinen und gallenstoerungen.
NO890259L (no) Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider.
ATE142877T1 (de) Melatoninderivate zur behandlung von schlafstörungen und zur pre-anästhesie
EP0335901A4 (en) Methods and compositions for the treatment of non-ige-mediated diseases
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
FI840748A0 (fi) Kinolonkarbonsyror, foerfarande foer deras framstaellning och dessa innehaollande antibakteriella aemnen
ATE71629T1 (de) Methylenphosphonalkylphosphinate, pharmazeutische zubereitungen und verfahren zur behandlung abnormalen kalzium- und phosphat-stoffwechsels.
DE3856594D1 (de) Mittel zur behandlung der alzheimer-krankheit
NO902800L (no) Fremgangsmaate for fremstilling av 11beta-aryl-4-oestrener.
ATE78696T1 (de) Arzneimittelzubereitung zur behandlung des immunmangels.
ATE124681T1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
ATE89728T1 (de) Verwendung von dihydroergotamin und seinen salzen zur lokalen behandlung trophischer stoerungen.
DE69429856D1 (de) Substituierte caprolactame und deren derivate verwendbar zur behandlung der hiv-krankheit
ATE151774T1 (de) Cyclopentanperhydrophenanthren-17-beta-(3-furyl - 3-derivate und pharmazeutische präparate davon, zur behandlung von kardiovaskulär-erkrankungen
DE68901172D1 (de) (-)-2-pyrazolinverbindung, deren optischen aufspaltung und therapeutisches agens zur behandlung von zerebralen gefaesskrankheiten, diese verbindung als aktives ingredient enthaltend.
DE3162277D1 (en) N-(4-phenyl-2-thiazolyl)-oxamidic-acid-2-ethoxyethylester, process for its preparation and pharmaceutical compositions containing this compound
NO913685L (no) Fremgangsmaate for fremstilling av kalsiumopptaksinhibitorer.
DE59410340D1 (de) Verwendung von Bradykinin-Antagonisten zur Behandlung von Viruserkrankungen
DE3668116D1 (de) Zusammensetzung zur behandlung von infektionen.
DE69022027D1 (de) 2-Alkyl-3-benzoylbenzofurane zur Behandlung von Herzarrhythmia.
ATE121935T1 (de) D-asparaginsäure-beta-hydroxamat zur behandlung viraler infektionen und tumoren.
DE3883754D1 (de) Mittel zur prophylaxe und behandlung von viralen infektionskrankheiten.
NO900616L (no) Fremgangsmaate for fraksjonering av avlinger i industrieltraamateriale.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee